| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/05/2010 | US20100196476 Process for the preparation and pharmaceutical formulations for 4-quinolinones and quinolines and use thereof |
| 08/05/2010 | US20100196458 Modified cytokines for use in cancer therapy |
| 08/05/2010 | US20100196445 Systems and methods for delivery of biologically active agents |
| 08/05/2010 | US20100196440 Implant Material |
| 08/05/2010 | US20100196437 Medical devices having a surface including a biologically active agent therein |
| 08/05/2010 | US20100196429 Oil-In-Water Emulsion Composition And Method For Producing The Same |
| 08/05/2010 | US20100196418 UNIVERSAL CARRIER FOR TARGETING MOLECULES TO Gb3 RECEPTOR EXPRESSING CELLS |
| 08/05/2010 | US20100196407 Tick galectin |
| 08/05/2010 | US20100196399 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions |
| 08/05/2010 | US20100196396 Compositions and methods for modulating ghrelin-mediated conditions |
| 08/05/2010 | US20100196390 Agonist anti-trkb monoclonal antibodies |
| 08/05/2010 | US20100196383 Connective Tissue Growth Factor (CTGF-3) |
| 08/05/2010 | US20100196378 Removal promoters and inhibitor for apoptosis cells in vivo |
| 08/05/2010 | US20100196368 Substituted benz-azoles and methods of their use as inhibitors of raf kinase |
| 08/05/2010 | US20100196335 Methods and Compositions for Regulated Expressions of Nucleic Acid at Post-Transcriptional Level |
| 08/05/2010 | US20100196297 Urine as a source of alternative cellular energy pigments (ACE-pigments) in the Assesment and therapy of diseases |
| 08/05/2010 | US20100196283 Method and imaging medium for use in the method |
| 08/05/2010 | US20100196279 Treatment of gaucher disease with specific pharmacological chaperones and monitoring treatment using surrogate markers |
| 08/05/2010 | US20100196264 Use of somatostatin analogs in myocardial perfusion imaging |
| 08/05/2010 | DE202009017877U1 Lektinzusammensetzung zur Prophylaxe und/oder Behandlung von unerwünschten Arzneimittelnebenwirkungen Lektinzusammensetzung for the prophylaxis and / or treatment of adverse drug side effects |
| 08/05/2010 | CA2750452A1 N-acyl anthranilic acid derivative or salt thereof |
| 08/05/2010 | CA2749126A1 Oligomer-phenothiazine conjugates |
| 08/04/2010 | EP2213743A1 Albumin fusion proteins |
| 08/04/2010 | EP2213740A1 Human telomerase catalytic subunit |
| 08/04/2010 | EP2213737A1 Double-stranded oligonucleotides |
| 08/04/2010 | EP2213675A1 Pyridooxazepine derivative and use thereof |
| 08/04/2010 | EP2213673A1 Pyridone-substituted-dihydropyrazolopyrimidinone derivative |
| 08/04/2010 | EP2213305A1 Method for producing granulated matter |
| 08/04/2010 | EP2213303A1 Pharmaceutical composition for treatment of cataract |
| 08/04/2010 | EP2213301A1 Immune response inducer |
| 08/04/2010 | EP2213300A1 Composition and method for treating cancer using herpes virus |
| 08/04/2010 | EP2213292A1 Double-stranded oligonucleotides |
| 08/04/2010 | EP2213290A1 Agent for improving motor complications or psychiatric symptoms in parkinson's disease |
| 08/04/2010 | EP2211870A1 Cytidine analogs for treatment of myelodysplastic syndromes |
| 08/04/2010 | EP2211860A1 Combination therapy for reducing side effects using cannabinoid receptor ligands |
| 08/04/2010 | EP2211851A2 Laminins, derivatives, and compositions including same and method for their therapeutic use |
| 08/04/2010 | EP2211845A2 Glucocorticoid receptor antagonists such as mifepristone for treating cushing's syndrome |
| 08/04/2010 | EP1438015B1 Cosmetic and dermopharmaceutical compositions for skin prone to acne |
| 08/04/2010 | EP1343769B1 Benzoylpyridazines |
| 08/04/2010 | EP1045853B1 Synthesis of combretastatin a-4 prodrugs |
| 08/04/2010 | CN101796074A Anti-notch1 NRR antibodies and methods using same |
| 08/04/2010 | CN101795714A Method for promoting the expression of p53, and p53 expression promoter for use in the method |
| 08/04/2010 | CN101795704A Oral composition |
| 08/04/2010 | CN101792776A Recombinant adenovirus vector for efficiently inducing pluripotent stem cell (PS cell), method for inducing PS cell by using recombinant adenovirus vector and usage of recombinant adenovirus vector |
| 08/04/2010 | CN101792737A Culture method, application and combined preparation of hypoxia mesenchymal stem cell |
| 08/04/2010 | CN101792483A Novel peptides as NS3-serine protease inhibitors of hepatitis c virus |
| 08/04/2010 | CN101791355A Medicine composition used for preventing birth defects, improving memory and regulating immunity |
| 08/04/2010 | CN101791308A Combinations comprising epothilones and pharmaceutical uses thereof |
| 08/04/2010 | CN101791304A Application of Xyloketal B in preparing medicines for treating mitochondrial injury diseases |
| 08/03/2010 | US7767790 Apotosis inducing viral protein, in combination with defective p53 protein, for use in treatment of cell proliferative and autoimmune disorders |
| 08/03/2010 | US7767702 Combinations of oxazolidinones such as rivaroxaban with a platelet aggregation inhibitor such as a clopidogrel for the prophylaxis and/or treatment of thromboembolic disorders |
| 08/03/2010 | US7767699 Therapeutic agents useful for treating pain |
| 08/03/2010 | US7767693 inhibition of heat shock protein 90 (HSP90) comprising administering benzoyl compounds or prodrugs,as antitumor agents |
| 08/03/2010 | US7767679 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 08/03/2010 | US7767665 1,3-benzothiazinone derivatives and use thereof |
| 08/03/2010 | US7767450 Nucleotide sequences coding voltage-gated transport proteins for use as screening tools to identify modulators for treatment and prevention of nervous, muscular, glandular, immune, reproductive and epithelial tissue disorders |
| 08/03/2010 | US7767429 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes; transgenic animals; dosage forms; HYLENEX RECOMBINANT tradename |
| 08/03/2010 | US7767223 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use |
| 08/03/2010 | US7767208 Noninvasive vascular therapy |
| 08/03/2010 | CA2512926C Methods and compositions for inhibition of angiogenesis |
| 08/03/2010 | CA2490191C Modified 2' and 3' -nucleoside prodrugs for treating flaviviridae infections |
| 08/03/2010 | CA2480080C Composition for cell proliferation |
| 08/03/2010 | CA2468295C Glycoprotein remodeling using endoglycanases |
| 08/03/2010 | CA2461426C Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 08/03/2010 | CA2459311C 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 08/03/2010 | CA2444269C Treatment of disorders secondary to organic impairments |
| 08/03/2010 | CA2402199C Amidino compounds useful as nitric oxide synthase inhibitors |
| 08/03/2010 | CA2386325C Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes, dna viruses and retroviruses |
| 08/03/2010 | CA2312475C Method of suppressing .beta.-amyloid-related changes in alzheimer's disease |
| 08/03/2010 | CA2265853C Inhibition of apoptosis using interleukin-1.beta.-converting enzyme (ice)/ced-3 family inhibitors |
| 08/03/2010 | CA2247247C Troponin subunits and fragments useful as angiogenesis inhibitors |
| 07/29/2010 | WO2010084999A1 Immunosuppressive agents and prophylactic and therapeutic agents for autoimmune diseases |
| 07/29/2010 | WO2010084979A1 Benzodiazepin-2-on derivatives |
| 07/29/2010 | WO2010084944A1 NOVEL PYRROLO[2,3-d]PYRIMIDINE COMPOUND |
| 07/29/2010 | WO2010084798A1 Tricyclic compound |
| 07/29/2010 | WO2010084767A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity |
| 07/29/2010 | WO2010064958A3 Protein kinase c inhibitors exhibiting an anti-inflammatory, anti-allergic and anti-asthma effect |
| 07/29/2010 | WO2010045615A3 Treatment of organophosphate exposure with ocinaplon |
| 07/29/2010 | WO2006013193A8 Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalloproteinases inhibitors |
| 07/29/2010 | US20100192255 Novel Bacillus Thuringiensis Gene with Lepidopteran Activity |
| 07/29/2010 | US20100190838 Connective Tissue Growth Factor Fragments and Methods and Uses Thereof |
| 07/29/2010 | US20100190827 treating diseases responsive to cannabinoid receptor antagonism; using particular crystallization conditions, a novel stable crystalline form called form II is obtained |
| 07/29/2010 | US20100190756 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS |
| 07/29/2010 | US20100190693 Method for screening compounds & uses therefor |
| 07/29/2010 | US20100190211 IL-18 Receptors |
| 07/29/2010 | US20100189824 Triterpene compositions and methods for use thereof |
| 07/29/2010 | US20100189764 Bioactive mesh |
| 07/29/2010 | US20100189760 Synthetic Cell Platforms and Methods of Use Thereof |
| 07/29/2010 | US20100189720 Novel card proteins involved in cell death regulation |
| 07/29/2010 | US20100189708 Hydroxy piperidine derivatives to treat gaucher disease |
| 07/29/2010 | US20100189686 Albumin Fusion Proteins |
| 07/29/2010 | US20100189658 Imaging probes |
| 07/29/2010 | US20100189656 Contrast agents |
| 07/29/2010 | US20100189650 Near-Infrared Responsive Carbon Nanostructures |
| 07/29/2010 | DE10392697B4 Extrakt von Peptid-verknüpften Glucanen und Peptid-verknüpfte Clucane mit nachweisbarer oraler Resorbierbarkeit aus Coriolus Versicolor und deren Reinigungsverfahren und Verwendungen Extract of peptide-linked glucans and peptide-linked Clucane with detectable oral absorbability from Coriolus versicolor and their cleaning methods and uses |
| 07/29/2010 | CA2749700A1 Benzodiazepin-2-on derivatives |
| 07/29/2010 | CA2747801A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity |
| 07/28/2010 | EP2210878A1 Therapeutic agent for trpv1-mediated disease |
| 07/28/2010 | EP2210643A2 Combinations comprising epothilones and pharmaceutical uses thereof |
| 07/28/2010 | EP2210603A1 Pharmaceutical composition for inhibiting the accumulation of amyloid- b protein |